These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33576324)

  • 1. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis.
    Jin J; Yang L; Liu D; Li WM
    Technol Cancer Res Treat; 2021; 20():1533033820983085. PubMed ID: 33576324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Non-Small Cell Lung Cancer: A Meta-Analysis.
    Wang Y; Huang D; Xu WY; Wang YW; Che GW
    Oncol Res Treat; 2019; 42(10):523-531. PubMed ID: 31319409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis.
    Wang Y; Xu C; Zhang Z
    BMC Med; 2023 Dec; 21(1):486. PubMed ID: 38053096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis.
    Lee SF; Ng TY; Spika D
    BMC Cancer; 2019 Apr; 19(1):338. PubMed ID: 30971203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.
    Lin S; Fang Y; Mo Z; Lin Y; Ji C; Jian Z
    World J Surg Oncol; 2020 Jul; 18(1):186. PubMed ID: 32711514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Pretreatment D-Dimer Level in Small-Cell Lung Cancer: A Meta-Analysis.
    Li J; Wang Y; Li J; Che G
    Technol Cancer Res Treat; 2021; 20():1533033821989822. PubMed ID: 33563114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of lymphocyte to monocyte ratio in the prognosis of head and neck squamous cell carcinoma: a meta-analysis.
    Wei D; Liu J; Ma J
    PeerJ; 2023; 11():e16014. PubMed ID: 37719125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
    Ma JY; Liu Q
    Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of lymphocyte-to-monocyte ratio in patients with resectable pancreatic cancer: a systematic review and meta-analysis.
    Li H; Peng S; An R; Du N; Wu H; Zhen X; Gao Y; Li Z; Min J
    PeerJ; 2024; 12():e17585. PubMed ID: 39035167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.
    Xiang Q; Liu Y; Xiao J; Ou L; Du J
    Am J Mens Health; 2024; 18(2):15579883241234747. PubMed ID: 38514969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
    Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
    Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.
    Nishijima TF; Muss HB; Shachar SS; Tamura K; Takamatsu Y
    Cancer Treat Rev; 2015 Dec; 41(10):971-8. PubMed ID: 26481060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis.
    Li M; Deng Q; Zhang L; He S; Rong J; Zheng F
    Pathol Res Pract; 2019 Jan; 215(1):5-11. PubMed ID: 30401580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis.
    Li W; Ma G; Wu Q; Deng Y; Liu Y; Wang J
    Oncotarget; 2017 Dec; 8(66):110606-110613. PubMed ID: 29299172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High pretreatment D-dimer level is an independent unfavorable prognostic factor of small cell lung cancer: A systematic review and meta-analysis.
    Deng HY; Ma XS; Zhou J; Wang RL; Jiang R; Qiu XM
    Medicine (Baltimore); 2021 Apr; 100(15):e25447. PubMed ID: 33847650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
    Mei P; Feng W; Zhan Y; Guo X
    Front Immunol; 2023; 14():1321584. PubMed ID: 38090560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis.
    Gong J; Jiang H; Shu C; Hu MQ; Huang Y; Liu Q; Li RF
    J Ovarian Res; 2019 May; 12(1):51. PubMed ID: 31151469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet.
    Lin GN; Peng JW; Xiao JJ; Liu DY; Xia ZJ
    Med Oncol; 2014 Jul; 31(7):70. PubMed ID: 24927957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.
    Li J; Cheng Y; Ji Z
    Medicine (Baltimore); 2019 Jan; 98(2):e14091. PubMed ID: 30633220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis.
    Jin J; Yang L; Liu D; Li W
    BMJ Open; 2020 Jun; 10(6):e035031. PubMed ID: 32499266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.